These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10924611)

  • 1. An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease.
    Campbell SA; Shirey RS; King KE; Ness PM
    Transfusion; 2000 Jul; 40(7):828-31. PubMed ID: 10924611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemolysis of transfused A2 red cells by an auto-HI antibody.
    Darabi K; Makar RS
    Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic transfusion reaction due to anti-IH.
    Irani MS; Richards C
    Transfusion; 2011 Dec; 51(12):2676-8. PubMed ID: 21658050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
    Vichinsky EP; Luban NL; Wright E; Olivieri N; Driscoll C; Pegelow CH; Adams RJ;
    Transfusion; 2001 Sep; 41(9):1086-92. PubMed ID: 11552063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acute hemolytic transfusion reaction caused by an anti-P1 that reacted at 37 degrees C.
    Arndt PA; Garratty G; Marfoe RA; Zeger GD
    Transfusion; 1998 Apr; 38(4):373-7. PubMed ID: 9595020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-i causing acute hemolysis following a negative immediate-spin crossmatch.
    Judd WJ; Steiner EA; Abruzzo LV; Davenport RD; Oberman HA; Pehta JC; Nance SJ
    Transfusion; 1992; 32(6):572-5. PubMed ID: 1502712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A; Moreira G; Bordin JO
    Sao Paulo Med J; 1999 Jan; 117(1):38-9. PubMed ID: 10413970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A; Cash K; Uehlinger J
    Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction in children with sickle cell disease.
    de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
    Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
    Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
    Reyes MA; Illoh OC
    Immunohematology; 2008; 24(2):45-51. PubMed ID: 19852130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemolytic transfusion reaction associated with anti-Mt
    Claes V; Peyrard T; Deleers M; El Kenz H
    Transfusion; 2019 Nov; 59(11):3314-3318. PubMed ID: 31503331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ; Shenoy S; Goodnough LT
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.